Standard Operating Procedure for Response Timeline Control and Deadline Tracking
| Department | Regulatory Affairs |
| SOP No. | RA/2026/729 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 14/04/2026 |
| Effective Date | 14/04/2026 |
| Review Date | 14/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a systematic and controlled approach to managing response timelines and deadline tracking related to regulatory submissions, health authority queries, deficiency letters, and other compliance-related correspondences. The procedure ensures timely, accurate, and documented responses to maintain compliance with regulatory requirements, avoid delays in approval processes, and support the overall quality management system.
Scope
This SOP applies to all response timeline control and deadline tracking activities within the Regulatory Affairs department related to pharmaceutical products, dosage forms, regulatory submissions, deficiency management, health authority communications, and associated documentation. It includes all systems, records, and workflows utilized for tracking, escalating, and responding to regulatory inquiries and deadlines. Activities outside regulatory correspondence and response management are excluded.
Responsibilities
- Regulatory Affairs Executives/Officers: Execute day-to-day monitoring of response timelines and prepare responses.
- Regulatory Affairs Supervisors/Managers: Review response timelines, oversee adherence, and approve responses.
- Quality Assurance (QA): Verify compliance with timelines and documentation standards during audits and reviews.
- Documentation Control Personnel: Ensure proper filing, version control, and retention of response-related documents.
- Compliance Team: Monitor regulatory requirements and update the team on changes impacting timelines.
Accountability
The Regulatory Affairs Head is accountable for the effective implementation, ongoing compliance, periodic review, escalation of issues, and ensuring the overall effectiveness of the response timeline control and deadline tracking process outlined in this SOP.
Procedure
The response timeline control and deadline tracking procedure is designed to ensure all regulatory queries and deadlines are managed proactively and documented appropriately, adhering to current Good Manufacturing Practices (cGMP) and regulatory expectations.
1. Preparation and Prerequisites:
- Receive and log all health authority queries, deficiency letters, or regulatory requests immediately upon receipt.
- Verify the receipt date and any stated deadlines, deadlines imposed by internal policy, or regulatory body-specified timelines.
- Ensure all regulatory correspondence is complete and legible.
- Confirm access to tracking systems (manual or electronic) used for monitoring deadlines.
2. Timeline Establishment and Documentation:
- Enter the received query or request into the official tracking system with all relevant details including origin, subject, due date, and responsible personnel.
- Assign clear ownership to designated Regulatory Affairs personnel responsible for preparing the response.
- Set intermediate checkpoints in the timeline for draft completion, internal review, and approval stages.
- Identify regulatory requirements related to content, documentation, and format for the response.
3. Execution and Monitoring:
- Prepare the response according to applicable regulatory guidelines and internal SOPs.
- Conduct prerequisite reviews by subject matter experts and quality assurance before final approval.
- Document all review comments and corrective actions if applicable.
- Track progress daily and update status in the tracking system with any delays or deviations.
- Escalate delayed tasks immediately to the Regulatory Affairs Manager and QA as per escalation matrix.
4. Finalization and Submission:
- Obtain all necessary approvals on the final response document before submission.
- Submit the response to the regulatory authority within the predefined timeline using approved methods (e.g., electronic portal, courier).
- Record submission confirmation details, including date, time, method, and recipient information.
5. Post-Submission Controls:
- File and archive submitted responses along with all supporting documentation as per document retention policy.
- Conduct periodic audits on tracking logs to verify compliance and effectiveness.
- Review and update the SOP and tracking tools as necessary to incorporate lessons learned and regulatory changes.
- Train relevant personnel on any procedural updates to maintain compliance readiness.
6. Handling Deviations and Non-Compliance:
- Document any missed deadlines or delays in the deviation log.
- Investigate root causes and implement corrective and preventive actions.
- Report significant deviations to senior management and document corrective action completion.
All activities described above shall be performed in accordance with applicable regulatory guidelines, internal quality policies, and GxP standards to ensure integrity, traceability, and compliance of the response process.
Abbreviations
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- RA: Regulatory Affairs
- GxP: Good Practice (including GMP, GCP, GLP)
- cGMP: Current Good Manufacturing Practice
- API: Active Pharmaceutical Ingredient
- CTD: Common Technical Document
Documents
- Response Timeline Tracking Log (Annexure-1)
- Regulatory Query Response Template (Annexure-2)
- Deviation Report Form for Missed Deadlines (Annexure-3)
References
- ICH Q10 Pharmaceutical Quality System
- FDA Guidance for Industry – Responding to Inspection Observations (Form FDA 483)
- EU GMP Annex 11 – Computerised Systems
- WHO Technical Report Series on Post Approval Change Management
- Internal Document Control and Quality Policy
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Response Timeline Tracking Log
| Field | Description / Example |
|---|---|
| Reference Number | HAQ-2026-001 |
| Date Received | 01/04/2026 |
| Originating Authority | European Medicines Agency |
| Subject | Deficiency Letter for Product XYZ |
| Deadline Date | 21/04/2026 |
| Responsible Person | Regulatory Officer |
| Status | In Progress |
| Notes | Initial review completed, drafting response |
Annexure-2: Regulatory Query Response Template
| Field | Example Content |
|---|---|
| Header | Response to Deficiency Letter HAQ-2026-001 |
| Date | 15/04/2026 |
| To | European Medicines Agency |
| From | [Company Regulatory Affairs Department] |
| Subject | Submission of Requested Data and Clarifications for Product XYZ |
| Body | Please find enclosed the requested documentation addressing the concerns outlined in your letter dated 01/04/2026… |
| Attachments | Analytical Reports, Validation Summaries |
| Signature | Authorized Regulatory Representative |
Annexure-3: Deviation Report Form for Missed Deadlines
| Field | Example Data |
|---|---|
| Deviation No. | DEV-RA-026-001 |
| Date of Deviation | 23/04/2026 |
| Reference Number | HAQ-2026-001 |
| Description of Deviation | Response to deficiency letter submitted two days past the deadline. |
| Root Cause | Delay in collecting all necessary data from cross-functional teams. |
| Corrective Action | Implement improved data request timelines and monitor progress weekly. |
| Preventive Action | Establish cross-functional milestone meetings to identify potential delays early. |
| Reported By | Regulatory Affairs Supervisor |
| Reviewed By | Quality Assurance |
| Approved By | Regulatory Affairs Head |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 14/04/2026 | 1.0 | Initial issue | New SOP creation |